Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain

Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Speaker: Ashutosh D. Wechalekar, MD – University College Hospital

Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine

Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens

Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research

Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India

Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute

Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine

Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine

Speaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center

Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring

Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute

Speaker: Niccolo Bolli, Prof. – University of Milan

Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute

Speaker: Manoj Bhasin, PhD – Emory University

Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA

Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University

Speaker: Prashant Kapoor, MD – Mayo Clinic

Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université

Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA

Speaker: Claudio Cerchione, MD, PhD (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester

Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine

Speaker: Dave Murray, MD PhD – Mayo Clinic

Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain

Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute

Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital

Speaker: Meral Beksac, MD (she/her/hers) – Ankara University

Speaker: Natalie Callander, MD – University of Wisconsin

Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona

Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA

Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.